Background Both Takotsubo syndrome (TS) and ST-elevation myocardial infarction (STEMI) are conditions characterised by the ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular diseases, particularly acute myocardial infarction, are the leading cause of disability and ...

In frail, elderly patients with non-ST-segment elevation myocardial infarction (NSTEMI), invasive management with coronary ...

A strategy of administering a transfusion only when the hemoglobin level falls below 7 or 8 g per deciliter has been widely adopted. However, patients with acute myocardial infarction may benefit from ...

The preferred timing of treatment of nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) remains uncertain. A comparison of immediate percutaneous coronary ...

Empagliflozin stabilizes kidney function and reduces heart failure risk post-myocardial infarction, with eGFR remaining stable over 24 months. The EMPACT-MI trial confirmed empagliflozin's safety when ...

Cloud-Clone leverages its expertise in biological reagents, animal models, and primary cells to support global ...

Meta-analysis reveals 27 percent increased risk for incident acute myocardial infarction. (HealthDay News) — Patients with preexisting gastroesophageal reflux disease (GERD) have an increased risk for ...

New findings from the Northwell-Shock Registry show that while women with acute myocardial infarction-related cardiogenic ...